FOLFIRINOX + RT for Pancreatic Cancer

NCT01591733 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: FOLFIRINOX
DRUG: Capecitabine
RADIATION: Short Course Radiation
PROCEDURE: Surgery

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]